Why Eli Lilly (LLY) Is Buying Prevail Therapeutics (PRVL) For Up To $1.04 Billion

Eli Lilly Lifts Sales Guidance, Enters Gene Therapy Field With Prevail Acquisition

Eli Lilly to buy gene therapy developer Prevail in $1.04 billion deal

Prevail Therapeutics stock nearly doubles after Eli Lilly buyout deal